MY157743A - Emulsion-type liquid composition for oral cavity and process for production thereof - Google Patents

Emulsion-type liquid composition for oral cavity and process for production thereof

Info

Publication number
MY157743A
MY157743A MYPI2012001873A MYPI2012001873A MY157743A MY 157743 A MY157743 A MY 157743A MY PI2012001873 A MYPI2012001873 A MY PI2012001873A MY PI2012001873 A MYPI2012001873 A MY PI2012001873A MY 157743 A MY157743 A MY 157743A
Authority
MY
Malaysia
Prior art keywords
emulsion
oral cavity
type liquid
liquid composition
composition
Prior art date
Application number
MYPI2012001873A
Other languages
English (en)
Inventor
Yamaguchi Tsubasa
Nomura Yasuo
Original Assignee
Lion Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lion Corp filed Critical Lion Corp
Publication of MY157743A publication Critical patent/MY157743A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34Alcohols
    • A61K8/345Alcohols containing more than one hydroxy group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04Dispersions; Emulsions
    • A61K8/06Emulsions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34Alcohols
    • A61K8/347Phenols
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37Esters of carboxylic acids
    • A61K8/375Esters of carboxylic acids the alcohol moiety containing more than one hydroxy group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/39Derivatives containing from 2 to 10 oxyalkylene groups
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/86Polyethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Emergency Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Dispersion Chemistry (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
MYPI2012001873A 2009-12-22 2010-11-11 Emulsion-type liquid composition for oral cavity and process for production thereof MY157743A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2009290242 2009-12-22

Publications (1)

Publication Number Publication Date
MY157743A true MY157743A (en) 2016-07-15

Family

ID=44195392

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI2012001873A MY157743A (en) 2009-12-22 2010-11-11 Emulsion-type liquid composition for oral cavity and process for production thereof

Country Status (6)

Country Link
JP (1) JP5690744B2 (xx)
KR (1) KR101780837B1 (xx)
CN (1) CN102655844B (xx)
HK (1) HK1173960A1 (xx)
MY (1) MY157743A (xx)
WO (1) WO2011077847A1 (xx)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5953608B2 (ja) * 2012-05-25 2016-07-20 日本ゼトック株式会社 バイオフィルム抑制剤
JP6331641B2 (ja) * 2014-04-21 2018-05-30 ライオン株式会社 液体口腔用組成物、その製造方法及び前記組成物でのアラントイン又はその誘導体の低温安定化方法
MY180534A (en) * 2014-04-21 2020-12-01 Lion Corp Liquid composition for oral use and method for improving resilience to freezing thereof
JP6634284B2 (ja) * 2015-12-25 2020-01-22 日油株式会社 濃縮抗菌剤組成物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005179231A (ja) * 2003-12-18 2005-07-07 Lion Corp 液体口腔用組成物
JP4873154B2 (ja) * 2004-12-24 2012-02-08 ライオン株式会社 液体口腔用組成物
JP2006182662A (ja) * 2004-12-27 2006-07-13 Lion Corp 歯磨剤組成物
KR101380508B1 (ko) * 2006-06-23 2014-04-01 라이온 가부시키가이샤 이소프로필메틸페놀 함유 액체 구강용 조성물

Also Published As

Publication number Publication date
CN102655844A (zh) 2012-09-05
JP5690744B2 (ja) 2015-03-25
KR20120112538A (ko) 2012-10-11
KR101780837B1 (ko) 2017-09-21
JPWO2011077847A1 (ja) 2013-05-02
WO2011077847A1 (ja) 2011-06-30
CN102655844B (zh) 2014-07-09
HK1173960A1 (en) 2013-05-31

Similar Documents

Publication Publication Date Title
UA94052C2 (xx) Похідні піридазину$производные пиридазина
RU2009138047A (ru) Стабилизация витамина в12
MX2007013084A (es) Pirrolopiridinas sustituidas, composiciones que las contienen, proceso de fabricacion y utilizacion.
WO2007145991A3 (en) Anti-inflammatory and analgesic compositions and related methods
ATE527985T1 (de) Zusammensetzungen zur hautaufhellung
WO2006113631A3 (en) Bioenhanced compositions
CA2757418C (en) Pharmaceutical formulations comprising nitrocatechol derivatives and methods of making the same
MY140841A (en) Indozolone derivatives as 11b-hsd1 inhibitors
MY157743A (en) Emulsion-type liquid composition for oral cavity and process for production thereof
MY157740A (en) Liquid oral composition and method for producing same
MY139522A (en) New alkyl-pyridines as 11-beta inhibitors for diabetes
EA201071167A1 (ru) Стабилизированные олеосомные композиции и способы их получения
CY1116490T1 (el) Φαρμακευτικες συνθεσεις κλεβιδιπινης και μεθοδοι για την παραγωγη συγκεντρωσεων χαμηλων προσμιξεων των ιδιων
MX2019012939A (es) Formulaciones que contienen linaclotida para administracion oral.
HK1099032A1 (en) Esters of hyaluronic acid with rhein, process for their preparation and compositions comprising the same
UA110013C2 (uk) Застосування композиції для лікування шарко-марі-тута і пов'язаних з нею розладів
WO2013117770A3 (en) Cosmetic treatment method, and composition comprising a glyoxylic acid ester
WO2009015856A3 (de) Phosphorsäureester enthaltend über diol-einheiten verbrückte phosphoratome
PL1608346T3 (pl) Kompozycje dostarczające lek zawierające estry alfa-hydroksykwasów i sposób ich zastosowania
CA2798180A1 (en) Non-aqueous taxane pro-emulsion formulations and methods of making and using the same
TW200616616A (en) Paclitaxel aqueous injection solution and methods for preparing the same
HK1108633A1 (en) Stable pharmaceutical composition of fluoroether compound for anesthetic use, method for stabilizing a fluoroether compound, use of stabilizer agent for precluding the degradation of a fluoroether compound
MX2009003169A (es) Derivados de sulfonamida.
MY164603A (en) Liquid composition for oral cavity and method for stable addition of components to composition
DK1771180T3 (da) Sammensætninger i form af en spray, der omfatter en kombination af clobetasolpropionat og calcitriol, en alkoholfase og en oliefase